Implications of intermittent calcitriol therapy on growth and secondary hyperparathyroidism

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Pediatric nephrology (Berlin, West)

• Publication date

  2000-06-16

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s004670000352PMID 10912534
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Expression and signal transduction of calcium-sensing receptors in cartilage and bone.

  1999cited by this paper
• Risk factors for vertebral fractures in renal osteodystrophy.

  1999cited by this paper
• Expression and Signal Transduction of Calcium-Sensing Receptors in Cartilage and Bone1.

  1999cited by this paper
• Diminished linear growth during intermittent calcitriol therapy in children undergoing CCPD.

  1998cited by this paper
• Growth of long bones in renal failure: roles of hyperparathyroidism, growth hormone and calcitriol.

  1998cited by this paper
• Intermittent calcitriol therapy in secondary hyperparathyroidism: a comparison between oral and intraperitoneal administration.

  1998cited by this paper
• Reduced Concentration of Serum Growth Hormone (GH)-Binding Protein in Children with Chronic Renal Failure: Correlation with GH Insensitivity

  1997cited by this paper
• PTH/PTHrP receptor mRNA is down-regulated in epiphyseal cartilage growth plate of uraemic rats

  1996cited by this paper
• PTH/PTHrP receptor mRNA is down-regulated in epiphyseal cartilage growth plate of uraemic rats.

  1996cited by this paper
• Regulation of Rate of Cartilage Differentiation by Indian Hedgehog and PTH-Related Protein

  1996cited by this paper
• PTH/PTHrP Receptor in Early Development and Indian Hedgehog--Regulated Bone Growth

  1996cited by this paper
• Parathyroid hormone-related peptide delays terminal differentiation of chondrocytes during endochondral bone development.

  1996cited by this paper
• Bone disease in predialysis, hemodialysis, and CAPD patients: evidence of a better bone response to PTH.

  1995cited by this paper
• Calcitriol oral pulse therapy in children with renal osteodystrophy

  1995cited by this paper
• Lethal skeletal dysplasia from targeted disruption of the parathyroid hormone-related peptide gene.

  1994cited by this paper
• Biochemical markers of renal osteodystrophy in pediatric patients undergoing CAPD/CCPD.

  1994cited by this paper
• Development of adynamic bone in patients with secondary hyperparathyroidism after intermittent calcitriol therapy.

  1994cited by this paper
• Adynamic bone disease with negative aluminium staining in predialysis patients: prevalence and evolution after maintenance dialysis.

  1994cited by this paper
• Prospective trial of pulse oral versus intravenous calcitriol treatment of hyperparathyroidism in ESRD.

  1994cited by this paper
• Parathyroid hormone-related peptide-depleted mice show abnormal epiphyseal cartilage development and altered endochondral bone formation

  1994cited by this paper
• In vitro effects of growth hormone and other hormones on chondrocytes and osteoblast‐like cells

  1993cited by this paper
• The spectrum of bone disease in end-stage renal failure--an evolving disorder.

  1993cited by this paper
• Stimulating growth in uremic children.

  1992cited by this paper
• Is intermittent oral calcitriol safe and effective in renal secondary hyperparathyroidism?

  1991cited by this paper
• The effects of vitamin D metabolites on the plasma and matrix vesicle membranes of growth and resting cartilage cells in vitro.

  1988cited by this paper
• Bone disease in pediatric patients undergoing dialysis with CAPD or CCPD.

  1988cited by this paper
• The effects of intraperitoneal calcitriol on calcium and parathyroid hormone.

  1987cited by this paper
• Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients.

  1984cited by this paper
• Effects of 1,25-dihydroxyvitamin-D3 on renal function, mineral balance, and growth in children with severe chronic renal failure.

  1981cited by this paper
• Increased growth after long-term oral 1alpha,25-vitamin D3 in childhood renal osteodystrophy.

  1978cited by this paper
• A Review: Short Stature in Renal Disease

  1973cited by this paper

• Influence of Cinacalcet on Insulin-like Growth Factor-1 in Children on Regular Hemodialysis for End-stage kidney disease.

  2024cites this paper
• Do the intervals in growth hormone therapy positively affect the growth velocity?

  2020cites this paper
• Parathormone, bone alkaline phosphatase and 25-hydroxyvitamin D status in a large cohort of 1200 children and teenagers

  2020cites this paper
• Oral paricalcitol: expanding therapeutic options for pediatric chronic kidney disease patients

  2017cites this paper
• Clinical practice recommendations for treatment with active vitamin D analogues in children with chronic kidney disease Stages 2-5 and on dialysis.

  2017cites this paper
• Interventions for metabolic bone disease in children with chronic kidney disease.

  2015cites this paper
• The bone and mineral disorder of children undergoing chronic peritoneal dialysis.

  2010cites this paper
• Vitamin D deficiency and toxicity in chronic kidney disease: in search of the therapeutic window

  2010cites this paper
• Evaluation of Growth and Development

  2009cites this paper
• Vitamin D compounds for people with chronic kidney disease requiring dialysis.

  2009cites this paper
• Osteoporosis and cardiovascular disease: lessons from chronic kidney disease.

  2008cites this paper
• Hyperphosphatemia of chronic kidney disease.

  2008cites this paper
• Nutrition in children with CRF and on dialysis

  2007cites this paper
• The future of pediatric nephrology

  2005cites this paper
• Conjugated linoleic acid reduces parathyroid hormone in health and in polycystic kidney disease in rats.

  2004cites this paper
• Conjugated linoleic acid reduces parathyroid hormone in health and in polycystic kidney disease in rats 1 – 4

  2004cites this paper
• Surgical Approach to Secondary Hyperparathyroidism

  2003cites this paper
• Membrane receptors for vitamin D steroid hormones: potential new drug targets.

  2003cites this paper
• Elevated bone turnover in rat polycystic kidney disease is not due to prostaglandin E2

  2002cites this paper
• Renal function in meningomyelocele: risk factors, chronic renal failure, renal replacement therapy and transplantation

  2002cites this paper
• Renal medicine and renal transplantation

  2000cites this paper